135 related articles for article (PubMed ID: 12406530)
1. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
Martinez V; Christensen D; Kayser V
Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
[TBL] [Abstract][Full Text] [Related]
2. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
3. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
[TBL] [Abstract][Full Text] [Related]
4. Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
Christensen D; Gautron M; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):433-440. PubMed ID: 10568851
[TBL] [Abstract][Full Text] [Related]
5. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
[TBL] [Abstract][Full Text] [Related]
6. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to morphine analgesia: evidence for stimulus intensity as a key factor and complete reversal by a glycine site-specific NMDA antagonist.
Adam F; Bonnet F; Le Bars D
Neuropharmacology; 2006 Aug; 51(2):191-202. PubMed ID: 16713606
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.
Kayser V; Lee SH; Guilbaud G
Neuroscience; 1995 Jan; 64(2):537-45. PubMed ID: 7700537
[TBL] [Abstract][Full Text] [Related]
9. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats.
Walker J; Catheline G; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):509-516. PubMed ID: 10568859
[TBL] [Abstract][Full Text] [Related]
10. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
11. Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus.
Bordi F; Quartaroli M
Pain; 2000 Feb; 84(2-3):213-24. PubMed ID: 10666526
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats.
Pelissier T; Laurido C; Kramer V; Hernández A; Paeile C
Eur J Pharmacol; 2003 Sep; 477(1):23-8. PubMed ID: 14512094
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery.
Zhang GH; Min SS; Seol GH; Lee KS; Han H; In Kim Y; Han HC
Pain; 2009 Jun; 143(3):233-237. PubMed ID: 19361925
[TBL] [Abstract][Full Text] [Related]
14. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
15. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
16. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain.
Mao J; Price DD; Mayer DJ
Pain; 1995 Jun; 61(3):353-364. PubMed ID: 7478678
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.
Kayser V; Latrémolière A; Hamon M; Bourgoin S
Eur J Pain; 2011 May; 15(5):451-8. PubMed ID: 20965753
[TBL] [Abstract][Full Text] [Related]
18. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
[TBL] [Abstract][Full Text] [Related]
20. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
